OPK

1.32

2.22% -0.03

Dopo l'orario di chiusura: 1.31 -0.01 -0.76%

Opko Health Inc (OPK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché OPK Giù? Forum Previsione

Precedente Chiudi:

$1.35

Aprire:

$1.35

Volume 24 ore:

2.56M

Relative Volume:

0.81

Capitalizzazione di mercato:

$996.72M

Reddito:

$581.12M

Utile/perdita netta:

$-212.92M

Rapporto P/E:

-4.821

EPS:

-0.2738

Flusso di cassa netto:

$-174.22M

1 W Prestazione:

-1.12%

1M Prestazione:

-12.00%

6M Prestazione:

+6.45%

1 anno Prestazione:

+3.94%

Intervallo 1D:

$1.32

$1.38

Intervallo di 1 settimana:

$1.28

$1.38

Portata 52W:

$0.9769

$1.73

Opko Health Inc Stock (OPK) Company Profile

Nome

Opko Health Inc

Settore

Healthcare (1072)

Industria

Diagnostics & Research (49)

Telefono

305-575-4181

Indirizzo

4400 BISCAYNE BLVD., MIAMI, FL

Dipendente

2,275

Cinguettio

Prossima data di guadagno

2026-07-27

Ultimi documenti SEC

OPK's Discussions on Twitter

Compare OPK vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OPK Opko Health Inc	1.32	936.31M	581.12M	-212.92M	-174.22M	-0.2738
TMO Thermo Fisher Scientific Inc	580.02	207.93B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	199.98	138.14B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	590.00	43.87B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	141.34	38.94B	7.23B	1.41B	1.09B	4.979
WAT Waters Corp	399.70	36.45B	3.77B	449.25M	240.68M	7.8556

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-20	Iniziato	JP Morgan	Neutral
2025-10-31	Downgrade	Jefferies	Buy → Hold
2025-04-25	Iniziato	JP Morgan	Neutral
2023-06-29	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-12-15	Iniziato	H.C. Wainwright	Buy
2022-01-24	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-06-21	Iniziato	Ladenburg Thalmann	Buy
2019-11-25	Iniziato	Piper Jaffray	Overweight
2018-03-02	Downgrade	JP Morgan	Neutral → Underweight
2017-09-14	Downgrade	JP Morgan	Overweight → Neutral
2016-06-21	Reiterato	Standpoint Research	Buy
2016-06-03	Iniziato	Standpoint Research	Buy
2016-03-31	Reiterato	Barrington Research	Outperform
2015-10-16	Iniziato	JP Morgan	Overweight
2015-09-11	Downgrade	Jefferies	Buy → Hold
2015-03-03	Downgrade	Oppenheimer	Outperform → Perform
2014-05-12	Reiterato	Oppenheimer	Outperform
2014-03-14	Iniziato	Oppenheimer	Outperform
2013-11-13	Reiterato	Ladenburg Thalmann	Buy
2013-05-30	Reiterato	Ladenburg Thalmann	Buy
2012-10-22	Iniziato	Barrington Research	Outperform
2011-12-01	Reiterato	Ladenburg Thalmann	Buy
2011-07-14	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Opko Health Inc Borsa (OPK) Ultime notizie

Jul 28, 2026

Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results - Benzinga

Jul 28, 2026

OPKO Health (NASDAQ:OPK) Shares Gap Up Following Strong Earnings - MarketBeat

Jul 28, 2026

Why Is OPKO Health (NASDAQ:OPK) Stock Drawing Fresh Market Interest Today? - Kalkine Media

Jul 28, 2026

OPK Looks 19.0% Overvalued on GF Value™ - GuruFocus

Jul 28, 2026

Jul 27, 2026

OPKO Health, Inc. 2026 Q2 10-Q Report: Financial Statements, Risk Factors, and Management Discussion - Minichart

Jul 27, 2026

OPK Looks 17.9% Overvalued on GF Value™ - GuruFocus

Jul 27, 2026

OPKO Health Q2 2026 Results: Key Pipeline Advances, Rayaldee China Expansion, and Improved Financial Performance – Minichart - Minichart

Jul 27, 2026

OPKO Health (NASDAQ:OPK) Shares Rise After Q2 Earnings Exceed Forecasts; Nicoya Agreement Lifts After-Hours Gains - TechStock²

Jul 27, 2026

Earnings call transcript: OPKO Health posts smaller Q2 loss, shares rise in 2026 - Investing.com Canada

Jul 27, 2026

OPK: Q2 2026 delivered higher revenue, improved margins, and raised full-year guidance amid pipeline advances - TradingView

Jul 27, 2026

OPKO Health Q2 Earnings Call Highlights - MarketBeat

Jul 27, 2026

Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Jul 27, 2026

OPK: Profitability improved and revenue grew in Q2 2026, with guidance raised for the full year - TradingView

Jul 27, 2026

OPKO Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 27, 2026

OPKO Health Q2 EPS beats estimates as sales rise 4.3% to $163.5 million - scanx.trade

Jul 27, 2026

OPKO Health (NASDAQ:OPK) Issues Earnings Results - MarketBeat

Jul 27, 2026

OPKO HEALTH ($OPK) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative

Jul 27, 2026

OPKO HEALTH, INC. Q2 2026: Revenue $163.6M, EPS $(0.01) — 10-Q Summary - TradingView

Jul 27, 2026

OPKO Health: Q2 Earnings Snapshot - Yahoo Finance

Jul 27, 2026

(OPK) OPKO Health, Inc. Expects Q3 Revenue Range $131.0M$142.0M - marketscreener.com

Jul 27, 2026

OPKO Health reports Q2 2026 revenue $163.5M, operating loss narrows to $7.0M, net loss $8.4M - TradingView

Jul 27, 2026

OPKO Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Jul 27, 2026

OPK: Q2 2026 revenue rose and losses narrowed, with clinical and partnership progress highlighted - TradingView

Jul 27, 2026

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results - OPKO Health, Inc.

Jul 27, 2026

OPKO Begins Phase 1 Trials in B-Cell Lymphoma, COVID Prevention - Stock Titan

Jul 27, 2026